Coater Modul for MINILAB XP
The MINILAB XP by DIOSNA is a well-known laboratory processor. With our new Coater Modul we offer a unit with a fluid bed processor and a horizontal coater in one.
DIOSNA Dierks & Söhne is a well-known supplier of pharmaceutical equipment with customers all over the world. Mixer-granulators, fluid bed processors, single pot systems and tablet coaters are essential DIOSNA components for our pharmaceutical clients. We offer a wide range of equipment from laboratory, over pilot to production scale.
With our new Coater Modul for the DIOSNA laboratory fluid bed processor MINILAB XP we expand the functions of our flexible and popular laboratory processer by one more important topic of the pharmaceutical industry in just one unit.
The Coater Module operates like a horizontal coater and has an inspection glass on the lid for a good process observation. The use of the Coater Module for film-coating in laboratory scale allows working with batch sizes from 500g to 2kg. The complete module is easily changeable by a supporting frame that is included in scope of supply. Using the Coating Module highly increases the flexibility of the MINILAB XP and keeps the size of the MINILAB XP unit nearly the same. The comfortable handling and great reproducibility of the MINILAB XP remain as usual.
Contact Details:
Company name: DIOSNA Dierks & Söhne
Website: www.diosna.com
E-mail: laura.westermann@diosna.de
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
